the transfer of genetic material from a strain or species resistant to a particular drug to another strain previously sensitive. The discovery that such a transfer of drug resistance from a nonpathogenic species to a pathogenic species of Gram-negative bacilli can occur within the intestine of animals or man (Meynell and Datta, 1967; Watanabe, 1967) (Watanabe, 1963 ; Medeiros and O'Brien, 1966; Anderson, 1967) . Organisms apt to acquire transferred resistance include those causing dysentery, typhoid, urinary infections, cholera, and plague (Watanabe, 1967) . Transferred resistance has also been demonstrated in Klebsiella species (Medeiros and O'Brien, 1966) and staphylococci (McDonald, 1966) , both of which have obvious practical implications in the hospital environment. Genes transferred from the cytoplasmic bodies may confer resistance by altering the functions of the cell membrane. This alteration may consist in either decreasing the permeability of the membrane to the drug in question or in inducing the manufacture of drug-destroying enzymes which are released between the membrane and the cell wall (Richmond, 1966) .
Mechanisms of Transfer of Resistance
There are three main mechanisms by which genetic material conferring resistance may be transferred from a resistant to a sensitive strain (Watanabe, 1967 (Meynell and Datta, 1967 ; Watanabe, 1967 clinically. There is therefore little point in changing from one drug of this group to another unless it has been definitely shown that the organisms are sensitive to the second drug proposed.
In the group of reserve drugs the most important clinical consideration is the risk of cross-resistance between methicillin, cloxacillin, and cephaloridine.
There is virtually complete cross-resistance between methicillin and cloxacillin. This does not seem to be related to destruction by bacterial enzyme but possibly to some difference in the cell wall (Richmond and Stewart, 1966) . Strains resistant to methicillin are relatively rarely resistant to cephalosporin, but induction of resistance to cephalosporin is said usually to result in resistance to methicillin (and presumably cloxacillin) (Ott and Godzeski, 1966 ). There does not yet seem to be sufficient clinical information on this point, but meantime it seems wisest to give cephalosporin only under isolation conditions, as with methicillin and cloxacillin. Lists of known cross-resistance between drugs may be found elsewhere (Garrod and O'Grady, 1968; Crofton and Douglas, 1969) .
Clinical Implications of Drug Resistance
It will be clear from the above discussion that drug resistance is a very complex matter. Acquired drug resistance is of great importance to the clinician, for he must always seek to prevent it, when he is giving the relevant drugs, by using at least two drugs to which the organism is sensitive and which do not have cross-resistance between them. The problems associated with natural drug resistance imply that in any hospital environ- Another disturbing thought has been the suggestion that the R factor might be transferred from a resistant to a sensitive strain during resistance testing by the disc method, resulting in a misleading bacteriological report (Smith and Stewart, 1966 in the case of certain drugs, destroyed by metabolic processes in the liver and elsewhere, and some is excreted by the kidneys (Verwey et al., 1965) . The concentration drops sharply with the distance from the blood vessel unless the serum levels can be maintained for long periods, giving time for equilibrium to occur. This may be important in relatively avascular lesions, such as thick-walled abscesses. The drainage of an abscess will maintain tissue flow and thus assist diffusion (Sabath et al., 1962; Verwey et al., 1965) .
Membrane Barriers
The most well known of these is the blood-brain barrier. A relatively small amount of penicillin penetrates into the cerebrospinal fluid of normal people, though this may be larger in meningitis. Because of the low protein content of cerebrospinal fluid there is little protein-binding, so that most of the penicillin present is in the free state and therefore effective. Other drugs, such as isoniazid, penetrate the blood-brain barrier well.
Cell Barriers (Kessel, 1965) In some infections many bacteria are in the cytoplasm of host cells. The ability of antibiotics to penetrate the cells is therefore relevant to the outcome of treatment. The bacteria lie within a phagocytic vacuole in the cell. If the antibiotic penetrates the cell wall and membrane it lies in a pinocytic vacuole within the cytoplasm (Fig. 12) . After this the drug still requires to be transferred across the cytoplasm and to penetrate the wall of the vacuole containing the bacteria. It has been shown in the case of tetracycline, which can be identified by its fluorescent properties, that the drug in the pinocytic vacuole often fails to come in contact with the organisms in the phagocytic vacuole (du Buy et al., 1964 Kessel, 1965 Rolinson (1967) Kunin (1967) . The proportion also varies from one animal species to another. Most drugs are bound to albumin, but erythromycin binds to al-globulin.
It is only the free antibiotic which has antibacterial effect, but there is ready dissociation of the bound drug from protein as the free drug diffuses out into the tissues and is excreted through the kidney (Fig. 13) though, of course, the peak level in the lesion is reached later, and its height depends partly on the duration of the peak level in the blood. As the blood level falls, drug will tend to diffuse back into the blood stream from the tissues and from the lesion.
Protein-binding in tissues is relatively unimportant, partly because there is less free protein and partly because that in tissue binds less drug (Verwey et al., 1965 Rolinson (1967) shows in a useful table that in the case of drugs effective against staphylococci and taken in usual doses the peak serum level of free drug is several times the minimal inhibitory concentration as measured in vitro. A drug like novobiocin, which is 94% bound in serum, may compensate for this by maintaining its maximal level of free drug over long periods, allowing effective diffusion into the lesion. Rolinson (1967) also points out that it is much more meaningful to give the percentage of free drug in the blood rather than that of bound drug. For two drugs a difference in binding of between 90 and 95% sounds very little, but, in fact, the first gives a proportion of free drug twice that of the second.
Inactivation of Antibiotic by Host Flora
Theoretically an antibiotic such as penicillin might in some sites be inactivated by penicillinase produced by bacteria other than those causing the illness. For instance, in the prophylaxis of rheumatic fever by penicillin it was found that the elimination of haemolytic streptococci by penicillin might be prevented by the presence of penicillinase-producing staphylococci in the throat (Massell et al., 1966) . This is probably not a frequent phenomenon. Hafez et al. (1965) found no evidence that it occurred in the sputum of patients with respiratory infections treated with penicillin. Conclusions In this brief survey I have tried to outline some of the principles which underlie the formerly empirical subject of chemotherapy. I have done so partly because it is intellectually more satisfying to be able to visualize the processes which are going on both in the patient and in his invaders during the treatment of a bacterial infection. But, even more important, a grasp of the nature of these processes should-help the clinician to find answers to the minority of challenging problems of bacterial infection which, if inadequately met, may result in severe disability or death. A knowledge of principles enables the physician to ask the bacteriologist the right questions, and helps the bacteriologist to answer them. For both the whole subject becomes far more fascinating, and the ultimate beneficiary is the patient. 
